News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bayer Corporation Q4 Disappoints, Outlook Underwhelms
February 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Bayer issued a weaker than expected 2010 earnings forecast as high raw material costs undermine an upturn at its plastics division and low crop prices weigh on its pesticides unit.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Bayer
MORE ON THIS TOPIC
Manufacturing
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
September 22, 2026
·
2 min read
·
Nick Paul Taylor
IPO
2026 IPO blitz continues with 4 new biotech filings
September 22, 2026
·
4 min read
·
Tristan Manalac
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
September 22, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
BMS says goodbye to 265 New Jersey staff as reorg rolls on
September 22, 2026
·
95 min read
·
BioSpace Editorial Staff